about
Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans.Fluid balance, diuretic use, and mortality in acute kidney injury.High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III.Validation of CKD and related conditions in existing data sets: A systematic review.Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) StudySerum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting.Serum fibroblast growth factor-23 is associated with incident kidney disease.Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK).Listing for expanded criteria donor kidneys in older adults and those with predicted benefit.Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.Frailty, mycophenolate reduction, and graft loss in kidney transplant recipientsPlasma Urate and Risk of a Hospital Stay with AKI: The Atherosclerosis Risk in Communities Study.Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.Acute Kidney Injury After Major Surgery: A Retrospective Analysis of Veterans Health Administration Data.Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK).The effects of weight change on glomerular filtration rate.Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.Nephrolithiasis as a Risk Factor for CKD: The Atherosclerosis Risk in Communities Study.Metabolomics and Incidence of Atrial Fibrillation in African Americans: The Atherosclerosis Risk in Communities (ARIC) StudyRecipient age and time spent hospitalized in the year before and after kidney transplantation.Biomarkers of Vitamin D Status and Risk of ESRDKidney Function and Fracture Risk: The Atherosclerosis Risk in Communities (ARIC) StudyDietary Acid Load and Incident Chronic Kidney Disease: Results from the ARIC StudyAssociations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysisMultinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysisRecalibration of blood analytes over 25 years in the atherosclerosis risk in communities study: impact of recalibration on chronic kidney disease prevalence and incidence.Relation of serum phosphorus levels to the incidence of atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] study).Candidacy for kidney transplantation of older adultsBlood pressure excursions below the cerebral autoregulation threshold during cardiac surgery are associated with acute kidney injuryTrends in the inactive kidney transplant waitlist and implications for candidate survival.Fibroblast growth factor-23 and the long-term risk of hospital-associated AKI among community-dwelling older individuals.Sequelae of early hospital readmission after kidney transplantation.Frailty and early hospital readmission after kidney transplantation.Outcomes and worsening renal function in patients hospitalized with heart failure with preserved ejection fraction.Acute Kidney Injury in Patients on SGLT2 Inhibitors: A Propensity-Matched Analysis.Association of race and age with survival among patients undergoing dialysis.Reply to MF McCarty.Early hospital readmission after kidney transplantation: patient and center-level associations.Immediate monthly combination contraception to facilitate initiation of the depot medroxyprogesterone acetate contraceptive injection.Disparities in provision of transplant information affect access to kidney transplantation.
P50
Q30301317-7574AE83-EB3B-4F96-8848-5D421AB2821BQ30427055-7B73BC74-F527-4337-A8BF-D03EE0B258B1Q30564821-78B5DC6D-8A90-4145-AC87-B41468F23E5EQ33652007-313A2293-6646-4294-A5F0-E2E70F845066Q34084375-634DF5AA-B0EC-434F-B152-CA1D828A2BF2Q34254746-9C0D19E1-3F15-4F33-8AE6-F3F8966AC302Q34787817-AFFC525F-6F59-4653-8F94-089AAA2FD537Q35118016-4AA4081C-7C0E-443A-909F-31435A78BDFBQ35135224-3B244F40-25FF-4CEA-B5A3-900EC8A57E23Q35204621-8045E4C3-C5C1-4DF0-B341-5069A758E0DCQ35243472-9560042F-71EC-4770-AF34-7D819A37EEA2Q35576084-9A586A09-FB83-4CBF-8BE3-3BCC60BCF4D0Q35576129-3E5614F3-A1D7-4313-910D-683EC83A89D6Q35763952-E703964A-9208-4C7E-BD48-7E5668C8C6CFQ35886023-2E029AC2-A12F-4606-8215-4EE8EECA44D1Q36197733-8FFA553A-F92E-43A4-A67F-BC5845CEF345Q36250287-F0B32E1B-F4AE-499A-B54A-55F2F8FC619EQ36250333-2D4E0090-809E-4438-886F-6115BCBB2E76Q36257878-A0CE7994-6AC7-47F3-B19B-574CB9CE5458Q36300990-E4D9A64B-25E0-42A3-A6A5-F2AF19C46BE7Q36494759-7DD4EA66-3D00-4E1D-AEA9-8B7A0964C027Q36495030-59D08326-2F1B-4203-9095-A23EBA08ADE6Q36522360-C39FB4C8-C6D9-458C-BFED-C6913D986D75Q36572045-D33E7261-23B0-4F6B-A470-8C48363404EFQ36575996-D4D62674-A6C2-4AAA-8F59-408BB08D93D1Q36661937-673D677F-3769-48B8-9D60-7CC0287327F2Q36784276-B7FA3474-CFBA-4B56-8E59-0C6219B47EDBQ37139439-DB1CDFEB-C972-40FD-B3B3-5C86F865D5D1Q37161075-924E0218-686C-4575-AFBB-4D0C539F434AQ37482933-1651A76E-6A8D-440C-95A6-7EE3C7D28D0EQ37553093-DD962D47-F543-4414-A96E-15AAE8C4EEFDQ37721650-AE89363A-5ECA-47CE-AD70-7F48079BFDCEQ37724823-2A57A2D2-E9CE-46D4-A80A-8EF63CC149C3Q38593790-B8F85E3E-28F9-4864-8AA7-A455A8240C2BQ38615440-2C00C6CA-D62C-49B3-A19A-BA542B3DD042Q41985216-B28435A3-3BB7-492F-99CC-6D484B61A996Q42410670-06208C4D-A882-41F5-A393-EA5141B940ABQ43791782-55D7A422-EC55-41D6-A430-8CFF8029F667Q44945251-B228C417-9D09-4823-BCF6-66854FF03015Q45303544-FBA3CB23-4503-4DFB-8D2D-0A32CE5821E8
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Morgan E. Grams
@ast
Morgan E. Grams
@en
Morgan E. Grams
@es
Morgan E. Grams
@nl
Morgan E. Grams
@sl
type
label
Morgan E. Grams
@ast
Morgan E. Grams
@en
Morgan E. Grams
@es
Morgan E. Grams
@nl
Morgan E. Grams
@sl
prefLabel
Morgan E. Grams
@ast
Morgan E. Grams
@en
Morgan E. Grams
@es
Morgan E. Grams
@nl
Morgan E. Grams
@sl
P106
P1153
55882203700
P21
P31
P496
0000-0002-4430-6023